Cargando…
Is an Immunosuppressive Microenvironment a Characteristic of Both Intra- and Extraparenchymal Central Nervous Tumors?
In spite of intensive research, the survival rates of patients diagnosed with tumors of the central nervous system (CNS) have not improved significantly in the last decade. Immunotherapy as novel and efficacious treatment option in several other malignancies has failed in neuro-oncology likely due t...
Autores principales: | Soltani, Amina, Kajtar, Bela, Abdelwahab, El Husseiny Mohamed Mahmud, Steib, Anita, Horvath, Zsolt, Mangel, Laszlo, Jaromi, Luca, Pongracz, Judit E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830452/ https://www.ncbi.nlm.nih.gov/pubmed/35366268 http://dx.doi.org/10.3390/pathophysiology28010004 |
Ejemplares similares
-
KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
por: Jaromi, Luca, et al.
Publicado: (2021) -
Cisplatin treatment induced interleukin 6 and 8 production alters lung adenocarcinoma cell migration in an oncogenic mutation dependent manner
por: Kiss, Edit, et al.
Publicado: (2020) -
Reversible manifestations of extraparenchymal neurocysticercosis
por: Campos, Edison M., et al.
Publicado: (2018) -
Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features
por: Marcin Sierra, Mariana, et al.
Publicado: (2017) -
Low responsiveness of peripheral lymphocytes in extraparenchymal neurocysticercosis
por: Romo, Matthew L., et al.
Publicado: (2023)